SHATTERING THE
STATUS QUO
INTERVENTIONAL GLAUCOMA
iDose TR is a long duration intracameral
procedural pharmaceutical that delivers
prostaglandin analog therapy for the reduction
of intraocular pressure in patients with open-
angle glaucoma or ocular hypertension.
1
The catalyst to advance the interventional
glaucoma revolution, helping you and
your patients take back control of their
treatment journey.
Actual size
1.8mm x 0.5mm
©2024 Glaukos Corporation. All rights reserved. iDose TR and Glaukos are registered trademarks of Glaukos Corporation. PM-US-1761
INDICATIONS AND USAGE
iDose TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with
open angle glaucoma (OAG) or ocular hypertension (OHT).
IMPORTANT SAFETY INFORMATION
DOSAGE AND ADMINISTRATION
For ophthalmic intracameral administration. The intracameral administration should be carried out under standard aseptic conditions.
CONTRAINDICATIONS
iDose TR is contraindicated in patients with active or suspected ocular or periocular infections, patients with corneal endothelial cell dystrophy (e.g., Fuch's Dystrophy,
corneal guttatae), patients with prior corneal transplantation, or endothelial cell transplants (e.g., Descemet's Stripping Automated Endothelial Keratoplasty [DSAEK]),
patients with hypersensitivity to travoprost or to any other components of the product.
WARNINGS AND PRECAUTIONS
iDose TR should be used with caution in patients with narrow angles or other angle abnormalities. Monitor patients routinely to confirm the location of the iDose TR at the
site of administration. Increased pigmentation of the iris can occur. Iris pigmentation is likely to be permanent.
ADVERSE REACTIONS
In controlled studies, the most common ocular adverse reactions reported in 2% to 6% of patients were increases in intraocular pressure, iritis, dry eye, visual field defects,
eye pain, ocular hyperaemia, and reduced visual acuity.
Please see full Prescribing Information.
You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
You may also call Glaukos at 1-888-404-1644.
1. iDose TR (travoprost intracameral implant) 75 mcg Prescribing Information. Glaukos Corporation. 2023.
View full
prescribing
information at
iDoseTRhcp.com
